Literature DB >> 21518928

NKG2D receptor regulates human effector T-cell cytokine production.

Amorette Barber1, Charles L Sentman.   

Abstract

Although innate immune signals shape the activation of naive T cells, it is unclear how innate signals influence effector T-cell function. This study determined the effects of stimulating the NKG2D receptor in conjunction with the TCR on human effector CD8(+) T cells. Stimulation of CD8(+) T cells through CD3 and NKG2D simultaneously or through a chimeric NKG2D receptor, which consists of NKG2D fused to the intracellular region of CD3ζ, activated β-catenin and increased expression of β-catenin-induced genes, whereas T cells stimulated through the TCR or a combination of the TCR and CD28 did not. Activation by TCR and NKG2D prevented expression and production of anti-inflammatory cytokines IL-10, IL-9, IL-13, and VEGF-α in a β-catenin- and PPARγ- dependent manner. NKG2D stimulation also modulated the cytokine secretion of T cells activated simultaneously through CD3 and CD28. These data indicate that activating CD8(+) T cells through the NKG2D receptor along with the TCR modulates signal transduction and the production of anti-inflammatory cytokines. Thus, human effector T cells alter their function depending on which innate receptors are engaged in conjunction with the TCR complex.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518928      PMCID: PMC3123023          DOI: 10.1182/blood-2011-01-329417

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

Review 1.  Roles of the NKG2D immunoreceptor and its ligands.

Authors:  David H Raulet
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

2.  Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.

Authors:  Lauren I Richie Ehrlich; Kouetsu Ogasawara; Jessica A Hamerman; Rayna Takaki; Alessandra Zingoni; James P Allison; Lewis L Lanier
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

3.  NKG2D is a costimulatory receptor for human naive CD8+ T cells.

Authors:  Kerima Maasho; Jessica Opoku-Anane; Alina I Marusina; John E Coligan; Francisco Borrego
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

4.  Critical involvement of Tcf-1 in expansion of thymocytes.

Authors:  M W Schilham; A Wilson; P Moerer; B J Benaissa-Trouw; A Cumano; H C Clevers
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

5.  Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium.

Authors:  V Groh; S Bahram; S Bauer; A Herman; M Beauchamp; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

6.  Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo.

Authors:  X Xin; S Yang; J Kowalski; M E Gerritsen
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

Review 7.  The role of PPARs in inflammation and immunity.

Authors:  Robert B Clark
Journal:  J Leukoc Biol       Date:  2002-03       Impact factor: 4.962

8.  Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness.

Authors:  Nobuaki Miyahara; Bradley J Swanson; Katsuyuki Takeda; Christian Taube; Satoko Miyahara; Taku Kodama; Azzeddine Dakhama; Vanessa L Ott; Erwin W Gelfand
Journal:  Nat Med       Date:  2004-07-18       Impact factor: 53.440

9.  Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells.

Authors:  Jose R Conejo-Garcia; Fabian Benencia; Maria C Courreges; Eugene Khang; Lin Zhang; Alisha Mohamed-Hadley; Jeffrey M Vinocur; Ronald J Buckanovich; Craig B Thompson; Bruce Levine; George Coukos
Journal:  Cancer Biol Ther       Date:  2003 Jul-Aug       Impact factor: 4.742

Review 10.  Emerging roles of PPARs in inflammation and immunity.

Authors:  Raymond A Daynes; Dallas C Jones
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

View more
  21 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

Review 2.  Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy.

Authors:  Kushal Prajapati; Cynthia Perez; Lourdes Beatriz Plaza Rojas; Brianna Burke; Jose A Guevara-Patino
Journal:  Cell Mol Immunol       Date:  2018-02-05       Impact factor: 11.530

Review 3.  NKG2D ligands as therapeutic targets.

Authors:  Paul Spear; Ming-Ru Wu; Marie-Louise Sentman; Charles L Sentman
Journal:  Cancer Immun       Date:  2013-05-01

4.  Regulation of NKG2D+CD8+ T-cell-mediated antitumor immune surveillance: Identification of a novel CD28 activation-mediated, STAT3 phosphorylation-dependent mechanism.

Authors:  Jiemiao Hu; Izhar S Batth; Xueqing Xia; Shulin Li
Journal:  Oncoimmunology       Date:  2016-11-01       Impact factor: 8.110

5.  Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia.

Authors:  Maulik Vyas; Ann-Charlott Schneider; Olga Shatnyeva; Katrin S Reiners; Samir Tawadros; Stephan Kloess; Ulrike Köhl; Michael Hallek; Hinrich P Hansen; Elke Pogge von Strandmann
Journal:  Oncoimmunology       Date:  2016-07-15       Impact factor: 8.110

6.  T-cells expressing a chimeric-PD1-Dap10-CD3zeta receptor reduce tumour burden in multiple murine syngeneic models of solid cancer.

Authors:  Geoffrey Parriott; Kelsey Deal; Shane Crean; Elle Richardson; Emily Nylen; Amorette Barber
Journal:  Immunology       Date:  2020-04-07       Impact factor: 7.397

7.  Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.

Authors:  Adam Lynch; William Hawk; Emily Nylen; Sean Ober; Pierre Autin; Amorette Barber
Journal:  Immunology       Date:  2017-07-27       Impact factor: 7.397

8.  Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.

Authors:  Bryan McQueen; Kelsey Trace; Emily Whitman; Taylor Bedsworth; Amorette Barber
Journal:  Immunology       Date:  2016-01-17       Impact factor: 7.397

Review 9.  Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy: how far up the road have we traveled?

Authors:  Sarah K Tasian
Journal:  Ther Adv Hematol       Date:  2018-05-17

10.  Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy.

Authors:  Joana M Murad; Susanne H Baumeister; Lillian Werner; Heather Daley; Hélène Trébéden-Negre; Jake Reder; Charles L Sentman; David Gilham; Frederic Lehmann; Sarah Snykers; Marie-Louise Sentman; Terri Wade; Adam Schmucker; Michael W Fanger; Glenn Dranoff; Jerome Ritz; Sarah Nikiforow
Journal:  Cytotherapy       Date:  2018-06-29       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.